Ключевые слова:
type 1 diabetes mellitus, continuous glucose monitoring, insulin pump, OmniPod Dash, Dexcom G7, HbA1c, Time in Range, hypoglycemia, quality of life.Библиографические ссылки
1. American Diabetes Association. Standards of Medical Care in Diabetes. Diabetes Care. 2024.
2. American Diabetes Association. Diabetes Technology: Standards of Care in Diabetes. Diabetes Care. 2026.
3. Atkinson MA, Eisenbarth GS, Michels AW. Type 1 diabetes. Lancet.
4. Battelino T, Danne T, Bergenstal RM, et al. Clinical targets for continuous glucose monitoring data interpretation: recommendations from the international consensus on Time in Range. Diabetes Care.
5. Bergenstal RM, Garg S, Weinzimer SA, et al. Safety of a hybrid closed-loop insulin delivery system in patients with type 1 diabetes. New England Journal of Medicine.
6. Danne T, et al. ISPAD Clinical Practice Consensus Guidelines 2018: Insulin treatment in children and adolescents with diabetes. Pediatric Diabetes
7. International Diabetes Federation. IDF Diabetes Atlas. 10th edition. 2024.
8. International Society for Pediatric and Adolescent Diabetes. ISPAD
9. Clinical Practice Consensus Guidelines. 2024.
10. Nathan DM. Intensive diabetes treatment and cardiovascular outcomes in type 1 diabetes. Diabetes Care.
11. Pickup JC. Insulin pump therapy for type 1 diabetes mellitus. Diabetes Technology & Therapeutics.
12. Chiang JL, et al. Type 1 diabetes in children and adolescents:
13. World Health Organization. Global report on diabetes. 2023.
